The landscape of dementia analysis has advanced dramatically with the appearance of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-dependent tests that can detect Alzheimer's pathology yrs before indications emerge. When these technological developments characterize outstanding progress in understanding neurodegenerative